ESCRS - POCOR326 - Ai-Assisted Early Detection Of Keratoconus Using The Ocusmart Platform: Pilot Clinical Experience

Ai-Assisted Early Detection Of Keratoconus Using The Ocusmart Platform: Pilot Clinical Experience

Published 2026 - 44th Congress of the ESCRS

Reference: POCOR326 | Type: Poster | DOI: 10.82333/wyep-mn76

Authors: Dr Ghada Atta* 1 , A/Prof. Alfredo Di Giovanni 2

1ophthalmology,Clinic,Cologne ,Germany, 2ophthalmology,universty,Naples,Italy

Purpose

 

To evaluate the feasibility of using an AI-assisted digital platform (OcuSmart) for early detection of keratoconus and risk stratification prior to refractive surgery.

Setting

Single tertiary eye care center / refractive surgery clinic

Pediatric and adult patients presenting for routine refractive assessment or pre-surgery evaluation

Study period: January 2025 to December 2025

Ethics approval obtained; informed consent from all participants

Methods

Prospective pilot study including 50 patients (100 eyes) evaluated for refractive surgery or routine screening

Collected parameters: corneal topography indices (e.g., Kmax, corneal asymmetry), corneal thickness (pachymetry), age, AI-generated alerts for suspect keratoconus patterns

Primary outcomes: detection rate of early or forme fruste keratoconus, agreement with clinician assessment, intervention planning, or further imaging triggered by AI alerts

Results

50 patients (100 eyes), mean age 24 plus/minus 6 years

AI detected early keratoconus in 12 eyes (12 percent)

Agreement with clinician assessment: 10 out of 12 eyes (83 percent)

Intervention planning or further imaging was initiated in 10 eyes (83 percent) flagged by AI

Mean corneal thickness of flagged eyes: 485 um plus/minus 12 um

Mean Kmax in flagged eyes: 47.8 plus/minus 1.2 D

Conclusions

 

AI-assisted digital screening using the OcuSmart platform is feasible and effective for early keratoconus detection, showing high agreement with clinician assessment. Implementation of AI alerts may enhance patient safety in refractive surgery and enable proactive management of at-risk corneas.